BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 1332033)

  • 1. Dopamine receptor subtypes colocalize in rat striatonigral neurons.
    Surmeier DJ; Eberwine J; Wilson CJ; Cao Y; Stefani A; Kitai ST
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10178-82. PubMed ID: 1332033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons.
    Surmeier DJ; Kitai ST
    Prog Brain Res; 1993; 99():309-24. PubMed ID: 7906427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances.
    Cepeda C; Colwell CS; Itri JN; Chandler SH; Levine MS
    J Neurophysiol; 1998 Jan; 79(1):82-94. PubMed ID: 9425179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
    Robertson GS; Vincent SR; Fibiger HC
    Neuroscience; 1992 Jul; 49(2):285-96. PubMed ID: 1359451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
    Twery MJ; Thompson LA; Walters JR
    Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
    Pacheco-Cano MT; Bargas J; Hernández-López S; Tapia D; Galarraga E
    Exp Brain Res; 1996 Jul; 110(2):205-11. PubMed ID: 8836685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1-D2 dopamine receptor interaction: an in vivo single unit electrophysiological study.
    Murer MG; Riquelme LA; Tseng KY; Cristal A; Santos J; Pazo JH
    Neuroreport; 1997 Feb; 8(3):783-7. PubMed ID: 9106767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N; Nagao T; Ono H
    Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo.
    Tepper JM; Sun BC; Martin LP; Creese I
    J Neurosci; 1997 Apr; 17(7):2519-30. PubMed ID: 9065512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
    Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN; Rawji SS; Walters JR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 receptors modulate striatal dopamine release induced by the stimulation of both D1 and D2 receptors: in vivo voltammetric data revisited.
    Fechtali T; Issoual D; Abraini JH
    J Physiol Paris; 1994; 88(5):331-3. PubMed ID: 7787831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.